Rallybio Corporation
RLYB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $15,156 | $29,305 | $42,874 |
| - Cash | $32,122 | $9,445 | $14,779 | $13,903 |
| + Debt | $108 | $58 | $116 | $154 |
| Enterprise Value | – | $5,769 | $14,642 | $29,125 |
| Revenue | $212 | $212 | $212 | $38 |
| % Growth | 0% | 0% | 457.9% | – |
| Gross Profit | $212 | $212 | $212 | $8 |
| % Margin | 100% | 100% | 100% | 21.1% |
| EBITDA | $16,051 | -$10,031 | -$9,642 | -$11,578 |
| % Margin | 7,571.2% | -4,731.6% | -4,548.1% | -30,468.4% |
| Net Income | $16,016 | -$9,703 | -$9,439 | -$11,044 |
| % Margin | 7,554.7% | -4,576.9% | -4,452.4% | -29,063.2% |
| EPS Diluted | 0.36 | -0.22 | -0.21 | -0.25 |
| % Growth | 263.6% | -4.8% | 16% | – |
| Operating Cash Flow | -$6,550 | -$8,379 | -$10,205 | -$9,862 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6,550 | -$8,379 | -$10,205 | -$9,862 |